Steroid-resistant nephrotic syndrome: long-term evolution after sequential therapy
- 18 September 2007
- journal article
- Published by Springer Nature in Pediatric Nephrology
- Vol. 22 (11) , 1875-1880
Abstract
We present a retrospective study of 30 children of mean age 3.02 ± 1.81 years with steroid-resistant nephrotic syndrome (SRNS) treated with intravenous injection of methylprednisolone plus orally administered prednisone; 24 children also received cyclophosphamide (CP). Sixteen were resistant to steroids from the beginning, and 14 after a mean of 11.26 ± 16.61 months. The initial histological diagnosis was: 18 minimal change disease (MCD), 11 focal segmental glomerulosclerosis (FSGS) and one diffuse mesangial proliferative glomerulonephritis (DMPG). Total remission was achieved in 22 patients (73.3%), partial response in three (10%) and no response in five (16.6%), two of whom were brothers carrying an NPHS2 gene double mutation. There was no difference in response between the MCD and FSGS patients; the only patient with DMPG did not respond. Only initial resistance was a sign of bad prognosis. At follow-up (6.4 ± 3.6 years from last pulse), 21/22 were still in remission, 14/21 were without treatment. Six patients required cyclosporine or mycophenolate mofetil because of steroid dependence. Two non-responders developed end-stage renal failure (ESRF); the remaining patients maintained normal glomerular filtration. The treatment was well tolerated. In conclusion, most of the patients treated with sequential therapy consisting of methylprednisolone (MP) (100%) and CP (80%) showed remission and preserved renal function, but 20% developed steroid dependence.Keywords
This publication has 47 references indexed in Scilit:
- Mycophenolate mofetil in steroid/cyclosporine-dependent/resistant nephrotic syndromePediatric Nephrology, 2005
- Mycophenolate mofetil in the treatment of focal segmental glomerulosclerosisClinical Nephrology, 2004
- Efficacy of methylprednisolone pulse therapy in steroid-resistant nephrotic syndromePediatric Nephrology, 2004
- Patients with Mutations in NPHS2 (Podocin) Do Not Respond to Standard Steroid Treatment of Nephrotic SyndromeJournal of the American Society of Nephrology, 2004
- Intravenous pulse cyclophosphamide?is it effective in children with steroid-resistant nephrotic syndrome?Pediatric Nephrology, 2003
- Use of mycophenolate mofetil in steroid-dependent and -resistant nephrotic syndromePediatric Nephrology, 2003
- Corticosteroid-induced hypersensitivity reactionsAnnals of Allergy, Asthma & Immunology, 2002
- Combined therapy of tacrolimus and corticosteroids in cyclosporin‐resistant or ‐dependent idiopathic focal glomerulosclerosis: a preliminary uncontrolled study with prospective follow‐up†Nephrology Dialysis Transplantation, 2002
- Cyclophosphamide does not benefit patients with focal segmental glomerulosclerosisPediatric Nephrology, 1996
- Treatment of childhood steroid-resistant idiopathic nephrosis with a combination of cyclosporine and prednisoneThe Journal of Pediatrics, 1994